An Isoquinoline Scaffold as a Novel Class of Allosteric HIV‑1 Integrase Inhibitors

Allosteric HIV-1 integrase inhibitors (ALLINIs) are a new class of potential antiretroviral therapies with a unique mechanism of action and drug resistance profile. To further extend this class of inhibitors via a scaffold hopping approach, we have synthesized a series of analogues possessing an iso...

Full description

Saved in:
Bibliographic Details
Published in:ACS medicinal chemistry letters 2019-02, Vol.10 (2), p.215-220
Main Authors: Wilson, Tyler A, Koneru, Pratibha C, Rebensburg, Stephanie V, Lindenberger, Jared J, Kobe, Matthew J, Cockroft, Nicholas T, Adu-Ampratwum, Daniel, Larue, Ross C, Kvaratskhelia, Mamuka, Fuchs, James R
Format: Article
Language:English
Subjects:
Letter
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Allosteric HIV-1 integrase inhibitors (ALLINIs) are a new class of potential antiretroviral therapies with a unique mechanism of action and drug resistance profile. To further extend this class of inhibitors via a scaffold hopping approach, we have synthesized a series of analogues possessing an isoquinoline ring system. Lead compound 6l binds in the v-shaped pocket at the IN dimer interface and is highly selective for promoting higher-order multimerization of inactive IN over inhibiting IN-LEDGF/p75 binding. Importantly, 6l potently inhibited HIV-1NL4–3 (A128T IN), which confers marked resistance to archetypal quinoline-based ALLINIs. Thermal degradation studies indicated that at elevated temperatures the acetic acid side chain of specific isoquinoline derivatives undergo decarboxylation reactions. This reactivity has implications for the synthesis of various ALLINI analogues.
ISSN:1948-5875
1948-5875
DOI:10.1021/acsmedchemlett.8b00633